It was a Monday when Katie Lazdowski got the news no 33-year-old mother expects to hear: “You have breast cancer.” Waiting is never easy, but waiting to find out what’s next after a cancer diagnosis can be excruciating. After meeting with a local oncologist in Amherst, Mass., about two hours west of Boston, on Wednesday, … Read more
Whether you’re escaping the chill with a tropical vacation or skiing the slopes, sun safety is still important in the winter months. Because UV rays can be harmful even in frosty temperatures, protecting your skin is a year-round responsibility. Allison Goddard, MD, of Dana-Farber/Brigham and Women’s Cancer Center for Skin (Cutaneous) Oncology, shares some wintertime … Read more
Researchers in Dana-Farber’s Center for Neuro-Oncology are now launching attacks on glioblastomas from a new angle – by turning the patient’s immune system against the cancer cells. Where targeted chemotherapy uses drugs to disable proteins that cancer cells need to grow, immunotherapy drugs stimulate the patient’s immune system to recognize and kill cancer cells. Traditional drugs … Read more
Adam LaReau has seen courage. The 34-year-old Navy SEAL combat veteran spent 11 years serving his country, and has seen courage in the actions of his fellow SEALS and through the children of fallen comrades who must learn to grow up without their fathers. Now living in Boston, LaReau has found a way to channel … Read more
More than half of all people with cancer will get chemotherapy – powerful drugs that kill cancer cells to cure the disease, slow its growth, or reduce its symptoms. There are more than 100 different drugs used in chemotherapy, sometimes alone, but more often in combinations that have proven effective against specific types of cancer. … Read more
Close to 100,000 women are diagnosed with a gynecologic cancer in the United States each year. In recognition of Gynecologic Cancer Awareness Month, we’re taking a look at the main types of gynecologic cancers and their symptoms. Cervical cancer In cervical cancer, cancer cells form in the tissues of the cervix, the lower, narrow end … Read more
For many patients with brain tumors or other abnormal tissue located deep in the brain, treatment options have been limited. Last year, Jill Colter, now 50, discovered that a brain tumor resulting from Stage IV melanoma had returned. “Several years earlier, I had treatment with surgery and radiation, but the tumor came back,” Jill said. … Read more
Sometimes known as the “sunshine vitamin” because it’s produced by the body in response to sunlight, vitamin D is important for maintaining strong bones and ensuring healthy functioning of the lungs, cardiovascular system, immune system, and brain. Because of concerns that excessive sun exposure can lead to skin cancer, some people may avoid spending much … Read more
With summer around the corner, many will be heading to the beach to escape the heat. But before you spend time in the sun, Dana-Farber has a few tips to protect your skin and lower your risk of developing skin cancer. Do not use tanning booths Don’t hit the tanning bed for a “base tan” … Read more
Cancer affects thousands of men across the United States every year, with the most common diagnoses coming in the form of prostate, colon, testicular, lung, and skin cancer. Not all cancers can be detected early on, but for some forms of the disease, the spread of cancer can be prevented through screenings. As June marks … Read more
As patients come through for their MRIs and CT scans, MJ Murphy, RN, BS, has roughly 15 minutes to sit and talk, discuss treatment, and hear updates on friends and family. It’s not much time, but Murphy always tries to coax a smile. “I love referring to the friends and family in the waiting room … Read more
Reports of an experimental drug that slowed advanced breast cancer in a clinical trial have stirred excitement at a national research meeting and breathed new life into a cancer-fighting strategy that had seemed to falter. In one study, the drug, palbociclib, doubled the length of time without disease progression in patients with metastatic estrogen receptor-positive breast … Read more
Following radiation treatment or surgery to remove lymph nodes (lymphadenectomy), patients can develop lymphedema, a condition that involves abnormal swelling, usually in the arms or the legs, due to an accumulation of lymphatic fluids. This fluid buildup is caused by blockage or removal of lymph nodes or lymph vessels. Lymphedema is often associated with breast … Read more
Last month, the American Cancer Society (ACS) released “Cancer Statistics, 2014,” their annual estimate of new cancers diagnoses and deaths for the year ahead. The report was heavily focused on adult malignancies—not surprisingly, given that the number of adult cancer patients in the nation is orders of magnitudes greater than that of childhood patients—but did hold a … Read more
Immunotherapy – stimulating the body’s defenses to recognize and destroy disease-causing cells and proteins – was dubbed the “breakthrough of the year” in 2013 by Science magazine. Dana-Farber researchers have contributed many important discoveries over the years about how the immune system works. Now, they are building on these insights to develop immunotherapy against tumors … Read more
Though quite curable when diagnosed early, kidney cancer in advanced stages can become a stubborn disease. However, the outlook for patients with metastatic kidney cancer has brightened in the past several years. Oncologists have added to their arsenal a number of designer drugs that attack molecular targets – genetic abnormalities that drive tumors – with … Read more
Treatments that unleash the body’s own disease-fighting cells against cancer – an approach known as immunotherapy – have been heralded as the “Breakthrough of the Year” by Science magazine.
Dana-Farber Cancer Institute recently partnered with CancerConnect and Lakshmi Nayak, MD, to answer questions about brain cancer. Nayak is a neuro-oncologist in the Center for Neuro-Oncology at Dana-Farber/Brigham and Women’s Cancer Center and an instructor in neurology at Harvard Medical School. Q: There seems to be some progress concerning treatment of brain tumors, especially immunotherapy. … Read more
Physicians have long recognized that the same disease can behave differently from one patient to another, and that there is no one-size-fits-all treatment. In cancer, chemotherapy might dramatically shrink one lung tumor but prove ineffective against the same type of tumor in a different patient – even though tissue samples look identical under the microscope. … Read more
Highly malignant brain tumors called glioblastomas are the most common primary cancer of the brain; about 11,000 cases are diagnosed every year in the United States. Patrick Y. Wen, MD (Director) and David Reardon, MD, (Medical Director) of the Center for Neuro-Oncology at Dana-Farber/Brigham and Women’s Cancer Center describe the efforts to improve care for … Read more